Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2012:2012:628293.
doi: 10.1155/2012/628293. Epub 2012 Apr 1.

Understanding delayed T-cell priming, lung recruitment, and airway luminal T-cell responses in host defense against pulmonary tuberculosis

Christopher R Shaler  1 , Carly Horvath, Rocky Lai, Zhou Xing
Affiliations
Review

Understanding delayed T-cell priming, lung recruitment, and airway luminal T-cell responses in host defense against pulmonary tuberculosis

Christopher R Shaler et al. Clin Dev Immunol. 2012.

Abstract

Mycobacterium tuberculosis (M.tb), the causative bacterium of pulmonary tuberculosis (TB), is a serious global health concern. Central to M.tb effective immune avoidance is its ability to modulate the early innate inflammatory response and prevent the establishment of adaptive T-cell immunity for nearly three weeks. When compared with other intracellular bacterial lung pathogens, such as Legionella pneumophila, or even closely related mycobacterial species such as M. smegmatis, this delay is astonishing. Customarily, the alveolar macrophage (AM) acts as a sentinel, detecting and alerting surrounding cells to the presence of an invader. However, in the case of M.tb, this may be impaired, thus delaying the recruitment of antigen-presenting cells (APCs) to the lung. Upon uptake by APC populations, M.tb is able to subvert and delay the processing of antigen, MHC class II loading, and the priming of effector T cell populations. This delay ultimately results in the deferred recruitment of effector T cells to not only the lung interstitium but also the airway lumen. Therefore, it is of upmost importance to dissect the mechanisms that contribute to the delayed onset of immune responses following M.tb infection. Such knowledge will help design the most effective vaccination strategies against pulmonary TB.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Flow chart of TB disease progression and major events leading to protection. Major steps are outlined for the progression of and infected or uninfected hosts from the point of exposure to development of active disease or clinical latency (protection). The relative percentage of individuals to progress between steps is shown beside the appropriate progression line.
Figure 2
Figure 2
Illustration of the speculated major immunologic setbacks seen in the early course of pulmonary M.tb infection. The major defects are numbered in the diagram according to the sequence of events. APC: antigen-presenting cells; MLN: mediastinal lymph nodes.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Global tuberculosis control: key findings from the December 2009 WHO report. The Weekly Epidemiological Record. 2009;85:69–80. - PubMed
    1. Co DO, Hogan LH, Kim SI, Sandor M. Mycobacterial Granulomas: keys to a long-lasting host-pathogen relationship. Clinical Immunology. 2004;113(2):130–136. - PubMed
    1. Ehlers S. Immunity to tuberculosis: a delicate balance between protection and pathology. FEMS Immunology and Medical Microbiology. 1999;23(2):149–158. - PubMed
    1. Ferebee SH. Controlled chemoprophylaxis trials in tuberculosis. A general review. Bibliotheca tuberculosea. 1970;26:28–106. - PubMed
    1. Baussano I, Williams BG, Nunn P, Beggiato M, Fedeli U, Scano F. Tuberculosis incidence in prisons: a systematic review. PLoS Medicine. 2010;7(12) Article ID e1000381. - PMC - PubMed

Publication types

MeSH terms

Substances